Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence, Deaths, and Disability-Adjusted Life Years Due to Musculoskeletal Disorders for 195 Countries and Territories 1990–2017 Publisher Pubmed



Safiri S1 ; Kolahi AA2 ; Cross M3 ; Hill C4 ; Smith E5 ; Carsonchahhoud K6 ; Mansournia MA7 ; Almasihashiani A8 ; Ashrafiasgarabad A9 ; Kaufman J10 ; Sepidarkish M11 ; Shakouri SK12 ; Hoy D13 ; Woolf AD14 Show All Authors
Authors
  1. Safiri S1
  2. Kolahi AA2
  3. Cross M3
  4. Hill C4
  5. Smith E5
  6. Carsonchahhoud K6
  7. Mansournia MA7
  8. Almasihashiani A8
  9. Ashrafiasgarabad A9
  10. Kaufman J10
  11. Sepidarkish M11
  12. Shakouri SK12
  13. Hoy D13
  14. Woolf AD14
  15. March L3
  16. Collins G15
  17. Buchbinder R16
Show Affiliations
Authors Affiliations
  1. 1. Aging Research Institute, and School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  2. 2. Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Institute of Bone and Joint Research, The University of Sydney, Sydney, NSW, Australia
  4. 4. The Queen Elizabeth Hospital and the Royal Adelaide Hospitals, Adelaide, SA, Australia
  5. 5. Institute of Bone and Joint Research, and Pain Management Research Institute, The University of Sydney, Sydney, NSW, Australia
  6. 6. School of Health Sciences, University of South Australia, Adelaide, Australia
  7. 7. School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. School of Health, Arak University of Medical Sciences, Arak, Iran
  9. 9. School of Health, Bam University of Medical Sciences, Bam, Iran
  10. 10. Faculty of Medicine, McGill University, Montreal, QC, Canada
  11. 11. School of Public Health, Babol University of Medical Sciences, Babol, Iran
  12. 12. Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  13. 13. Institute of Bone and Joint Research, The University of Sydney, Sydney, New South Wales, Australia, and Global Alliance for Musculoskeletal Health, Royal Cornwall Hospital, Truro, United Kingdom
  14. 14. Royal Cornwall Hospital and University of Exeter Medical School, Truro, United Kingdom
  15. 15. Botnar Research Centre, University of Oxford, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
  16. 16. Cabrini Institute and School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia

Source: Arthritis and Rheumatology Published:2021


Abstract

Objective: To report the levels and trends of prevalence, deaths, and disability-adjusted life years (DALYs) due to musculoskeletal disorders, categorized as low back pain, neck pain, osteoarthritis (OA), rheumatoid arthritis (RA), gout, and other musculoskeletal disorders, across 195 countries and territories from 1990 to 2017 according to age, sex, and Sociodemographic Index (SDI; a composite of sociodemographic factors). Methods: Data were obtained from the Global Burden of Disease (GBD) Study 2017. The fatal and nonfatal burdens of musculoskeletal disorders were estimated using the Cause of Death Ensemble model and Bayesian meta-regression tool, respectively. Estimates were provided for all musculoskeletal disorders and the corresponding 6 categories at global, regional, and national levels from 1990 to 2017. Counts and age-standardized rates per 100,000 population along with 95% uncertainty intervals (95% UIs) were reported for prevalence, deaths, and DALYs. Results: Globally, there were ~1.3 billion prevalent cases (95% UI 1.2 billion, 1.4 billion), 121.3 thousand deaths (95% UI 105.6 thousand, 126.2 thousand), and 138.7 million DALYs (95% UI 101.9 million, 182.6 million) due to musculoskeletal disorders in 2017. Age-standardized prevalence, death, and DALY rates per 100,000 population were 16,276.2 (95% UI 15,495.5, 17,145.8), 1.6 (95% UI 1.4, 1.6), and 1,720 (95% UI 1,264.4, 2,259.2), respectively. Age-standardized prevalence (−1.6% [95% UI −2.4, −0.8]) and DALY rates (−3.5% [95% UI −4.7, −2.3]) decreased slightly from 1990. The global point prevalence rate of musculoskeletal disorders in 2017 was higher in women than in men and increased with age up to the oldest age group. Globally, the proportion of prevalent cases according to category of musculoskeletal disorders in 2017 was greatest for low back pain (36.8%), followed by other musculoskeletal disorders (21.5%), OA (19.3%), neck pain (18.4%), gout (2.6%), and RA (1.3%). These proportions did not change appreciably compared with 1990. The burden due to musculoskeletal conditions was higher in developed countries. The countries with the highest age-standardized prevalence rates of musculoskeletal disorders in 2017 were Switzerland (23,346.0 [95% UI 22,392.6, 24,329.8]), Chile (23,007.9 [95% UI 21,746.5, 24,165.8]), and Denmark (22,166.1 [95% UI 20,817.2, 23,542.1]). The greatest increases from 1990 were found in Chile (10.8% [95% UI 6.6, 15.4]), Benin (8.8% [95% UI 6.7, 11.1]), and El Salvador (8.5% [95% UI 5.5, 11.9]). Conclusion: There is a large burden of musculoskeletal disorders globally, with some notable inter-country variation. Some countries have twice the burden of other countries. Increasing population awareness regarding risk factors, consequences, and evidence-informed treatment strategies for musculoskeletal disorders with a focus on the older female population in developed countries is needed, particularly for low back and neck pain and OA, which contribute a large burden among this cohort. © 2020, American College of Rheumatology
Experts (# of related papers)
Other Related Docs